# Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers

> **NCT00369616** · PHASE2 · COMPLETED · sponsor: **Cytos Biotechnology AG** · enrollment: 341 (actual)

## Conditions studied

- Smokers

## Interventions

- **BIOLOGICAL:** CYT002-NicQb

## Key facts

- **NCT ID:** NCT00369616
- **Lead sponsor:** Cytos Biotechnology AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-03
- **Final completion:** 2005-10
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2010-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369616, "Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00369616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*